Ocean Bio-Chem, Inc. OBCI +1.02% , a leading manufacturer and distributor of appearance, performance, and maintenance products serving the marine, automotive, power sports, recreational vehicle and outdoor power equipment markets, is pleased to announce all-time record fourth quarter and full year net sales in 2013. Ocean Bio-Chem, Inc. (NASDAQ:OBCI) shares after opening at $2.99 moved to $2.99 on last trade day and at the end of the day closed at $2.96. Company price to sales ratio in past twelve months was calculated as 0.80 and price to cash ratio as 36.39. Ocean Bio-Chem, Inc. (NASDAQ:OBCI) showed a positive weekly performance of 1.37%.
The U.S. Environmental Protection Agency filed a complaint against Zep Inc., alleging the sale and distribution of an unregistered and misbranded pesticide for nearly two years. The EPA claims Atlanta-based Zep (NYSE: ZEP) sold “Formula 165” between April 21, 2010, and Jan. 6, 2012, in violation with the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).
Zep, Inc. (NYSE:ZEP) shares advanced 0.28% in last trading session and ended the day on $17.83. ZEP return on equity ratio is recorded as 10.10% and its return on assets is 3.30%. Zep, Inc. (NYSE:ZEP) yearly performance is 14.81%.
Stepan (NYSE:SCL) VP Frank Pacholec sold 1,400 shares of the stock on the open market in a transaction dated Thursday, March 6th. The stock was sold at an average price of $62.21, for a total value of $87,094.00. Following the sale, the vice president now directly owns 56,307 shares in the company, valued at approximately $3,502,858. Stepan Company (NYSE:SCL) shares moved up 0.31% in last trading session and was closed at $62.24, while trading in range of $61.76-$62.74. Stepan Company (NYSE:SCL) year to date performance is -4.89%.
Church & Dwight Co. (NYSE:CHD) was downgraded by research analysts at UBS AG from an “outperform” rating to a “neutral” rating in a report released on Wednesday, American Banking News reports. They currently have a $66.00 target price on the stock, up from their previous target price of $63.00. UBS AG’s price target points to a potential downside of 2.83% from the company’s current price. Church & Dwight Co., Inc. (NYSE:CHD) weekly performance is 0.06%. On last trading day company shares ended up $68.38. Church & Dwight Co., Inc. (NYSE:CHD) distance from 50-day simple moving average is 4.08%. Analysts mean target price for the company is $71.48.